S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain

NIKE (NKE) Price Target & Analyst Ratings

$114.76
-4.11 (-3.46%)
(As of 05/19/2023 08:48 PM ET)
Compare
Today's Range
$113.10
$115.49
50-Day Range
$114.76
$127.92
52-Week Range
$82.22
$131.31
Volume
11.67 million shs
Average Volume
5.87 million shs
Market Capitalization
$176.38 billion
P/E Ratio
33.07
Dividend Yield
1.19%
Price Target
$134.33

NIKE Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 36 Analyst Ratings

Consensus Analyst Price Target

$134.33
17.06% Upside
High Prediction$160.00
Average Prediction$134.33
Low Prediction$100.00
TypeCurrent
5/22/22 to 5/22/23
1 Month Ago
4/22/22 to 4/22/23
3 Months Ago
2/21/22 to 2/21/23
1 Year Ago
5/22/21 to 5/22/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
22 Buy rating(s)
22 Buy rating(s)
21 Buy rating(s)
25 Buy rating(s)
Hold
12 Hold rating(s)
12 Hold rating(s)
11 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$134.33$134.33$130.25$171.19
Predicted Upside17.06% Upside11.54% Upside20.08% Upside25.25% Upside
Get NIKE Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NKE and its competitors with MarketBeat's FREE daily newsletter.


NKE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NKE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

NIKE Stock vs. The Competition

TypeNIKEConsumer Discretionary CompaniesS&P 500
Consensus Rating Score
2.56
2.52
2.48
Consensus RatingModerate BuyBuyHold
Predicted Upside17.06% Upside87.21% Upside29.67% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/21/2023Williams Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Sell
3/28/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$140.00 ➝ $130.00+10.35%
3/28/2023Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$116.00 ➝ $123.00+4.41%
3/22/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$134.00 ➝ $148.00+17.83%
3/22/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$141.00 ➝ $142.00+13.05%
3/22/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$105.00 ➝ $112.00-10.84%
3/22/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Randal Konik
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$140.00 ➝ $160.00+27.38%
3/22/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$135.00 ➝ $145.00+15.44%
3/22/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$115.00 ➝ $125.00-0.49%
3/22/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$132.00 ➝ $143.00+13.84%
3/22/2023Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$145.00 ➝ $139.00+10.66%
3/22/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$130.00 ➝ $135.00+7.48%
3/22/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$130.00 ➝ $138.00+9.86%
3/22/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Binetti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$132.00 ➝ $139.00+10.66%
3/22/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$146.00 ➝ $142.00+13.05%
3/22/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jay Sole
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$151.00 ➝ $155.00+23.40%
3/22/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$110.00 ➝ $154.00+22.60%
3/22/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matthew Boss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight$156.00 ➝ $152.00+21.01%
3/17/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Piral Dadhania
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetOutperform$145.00+20.18%
3/17/2023Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$133.00 ➝ $138.00+14.38%
3/16/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$100.00-15.38%
3/10/2023OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMixed ➝ Positive
2/21/2023Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$135.00 ➝ $150.00+23.86%
1/12/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$100.00 ➝ $125.00-2.30%
1/10/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$131.00 ➝ $141.00+12.94%
1/10/2023KGI Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform
1/2/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aneesha Sherman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$122.00+4.26%
12/21/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$112.00 ➝ $120.00+2.31%
12/21/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$110.00 ➝ $120.00+16.27%
12/21/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$126.00 ➝ $133.00+28.86%
11/22/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$114.00 ➝ $118.00+12.74%
10/5/2022Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
10/3/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
8/9/2022Exane BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Laurent Vasilescu
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$118.00+3.51%
7/20/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Weight ➝ Sector Weight
6/22/2022Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kummetz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 5/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NKE Price Target - Frequently Asked Questions

What is NIKE's consensus rating and price target?

According to the issued ratings of 36 analysts in the last year, the consensus rating for NIKE stock is Moderate Buy based on the current 2 sell ratings, 12 hold ratings and 22 buy ratings for NKE. The average twelve-month price prediction for NIKE is $134.33 with a high price target of $160.00 and a low price target of $100.00. Learn more on NKE's analyst rating history.

Do Wall Street analysts like NIKE more than its competitors?

Analysts like NIKE more than other Consumer Discretionary companies. The consensus rating for NIKE is Moderate Buy while the average consensus rating for consumer discretionary companies is Buy. Learn more on how NKE compares to other companies.

Is NIKE being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, NIKE's stock had 2 upgrades and 1 downgrade by analysts.

Does NIKE's stock price have much upside?

According to analysts, NIKE's stock has a predicted upside of 11.54% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:NKE) was last updated on 5/22/2023 by MarketBeat.com Staff

My Account -